Now I have enough calibration data. Let me compile the final review with all comparisons.

**Bracket analysis:** The paper sits clearly above MCF (4.40) and MoreRed (4.75) — those anchors had fundamental novelty concerns and weaker evaluation. It is comparable to EQGAT-diff (5.75, accepted) in having a solid empirical contribution with some limitations, but has a more original conceptual contribution (DC-structure formalization + corrective sampling). It is slightly below SyCO (6.50, accepted) which had more thorough evaluation and transparent methodology. It is comparable to Megalodon (6.33, rejected) in quality. Placing it near VFDiff (6.00, rejected) — our paper is stronger because VFDiff's main criticism was extreme similarity to prior work, which doesn't apply here.

**Final score: 6.0**. The paper has a clear, well-motivated contribution with consistent empirical results, but the pilot score opacity in the main text and some imprecision in efficiency claims prevent a higher score.

---

## Summary
This paper identifies a "dense-concentrated structure" (DC-structure) in molecular data distributions — narrow, densely packed probability peaks separated by near-zero-density regions — and argues that this makes standard diffusion-based 3D molecular generation fragile because reverse steps can overshoot valid peaks. The authors propose DIST, a plug-in corrective sampling method that at an intermediate timestep evaluates pilot scores on batches of trajectories, filters out those that appear to have drifted off-distribution, and steers the remainder toward valid molecular configurations. Experiments apply DIST to three backbone diffusion models (EDM, GeoLDM, RADM) on QM9 and GEOM-Drugs, reporting consistent improvements in stability and validity metrics alongside reduced amortized inference timesteps.

## Strengths
- **Consistent improvements across architecturally diverse backbones**: Table 2 shows DIST improves all metrics across EDM (GNN-based equivariant), GeoLDM (latent-space), and RADM (Transformer-based non-equivariant) on both QM9 and GEOM-Drugs. QM9 molecule stability gains are substantial: EDM 82.0→89.9%, GeoLDM 89.4→93.4%, RADM 87.3→91.4%. This universality supports the claim that the DC-structure problem is architecture-agnostic and that DIST provides a complementary solution.
- **Clean empirical evidence for the error-accumulation thesis**: Table 1 shows monotonic degradation of all metrics as the starting reverse timestep increases (e.g., Mol Sta drops from 95.2→82.0 as t goes from 0→1000). This directly tests and validates the mechanism the paper proposes — that discrepancies accumulate over timesteps and intermediate drift is the root cause of failures.
- **Ablation study validates the correction mechanism**: Table 4 demonstrates that increasing pilot subset size (30→50→100) monotonically improves all quality metrics, consistent with the expectation that better representation of the intermediate distribution yields better correction.
- **Plug-in design with frozen backbone weights**: DIST is applied at inference time using official model weights without modification, making the model-agnostic claim falsifiable and the results reproducible without retraining.

## Weaknesses

### Fatal
None.

### Major
- **Pilot score mechanism not concretely specified in the main text**: Section 3.2 lists candidate pilot scores as "round-trip residual, self-consistency, ensemble variance, or chemistry-based penalty" (line 150) but never commits to which one is used in the experiments. The corrective sampling paragraph (lines 176–177) describes running "a full reverse inference on a pilot subset" to produce "an empirical assessment" but does not operationalize what metric is computed. If the score is chemistry-based (e.g., checking valency of fully denoised molecules), DIST functions largely as generate-and-filter with a domain oracle; if it is self-consistency-based, it is a more genuinely model-internal correction. The reader cannot determine what DIST fundamentally is from the main text alone. While the appendix likely specifies the choice, the pilot score is the operational core of the method and its nature affects the interpretation of results.

### Minor
- **Efficiency claim ("nearly half") is imprecise for some configurations**: Table 3 shows timesteps range from 413.7 (41% of baseline) to 636.7 (64%), so "nearly half" is accurate for the fastest configurations but misleading for the slower ones (e.g., GeoLDM+DIST on GEOM-Drugs at 636.7). Additionally, the amortized timestep accounting spreads the cost of discarded candidates across accepted samples; the actual computational savings depend on the acceptance rate, which is not reported in the main text.
- **No best-of-N baseline**: Since DIST effectively filters candidate trajectories using a pilot score, a natural baseline is simply generating N molecules from the backbone and selecting the best by the same score (without mid-trajectory intervention). This comparison would help isolate whether the benefit comes from mid-trajectory correction or simply from spending more compute on generation+filtering.
- **GEOM-Drugs results lack standard deviations**: Standard deviations are reported for QM9 but omitted for GEOM-Drugs, where the absolute improvements are more modest (e.g., Atom Stability +0.9–1.0 pp). Statistical significance of these gains cannot be assessed.
- **Theory-to-method connection is somewhat loose**: The DC-structure formalization (Definition 3.1) and the overshoot analysis (equations 6–7) motivate the general need for intermediate correction, but do not directly constrain specific design choices such as the intermediate timestep t, the batch radius r, or the threshold τ. Proposition 3.1's bound is a function signature in the main text with the actual bound deferred to Appendix E.2, so the reader cannot assess the strength of the theoretical guarantee without consulting supplementary material.

### Trivial
- The claim "We are the first to highlight that molecular data distributions are highly concentrated and dense" (line 27) is somewhat strong given that prior work (including cited papers by Hoogeboom et al. 2022 and Xu et al. 2023) has extensively discussed challenges from discreteness and geometric constraints in molecular data. The DC-structure framing is novel, but the underlying observation has precursors.

## Nice-to-Haves
- Ground the theoretical framework more tightly in the method: for instance, use the DC-structure parameters to derive the optimal intermediate timestep t or batch radius r, rather than treating these as empirical hyperparameters.
- Discuss the relationship to classifier guidance and classifier-free guidance, which are standard techniques for steering diffusion trajectories.
- Report wall-clock time or total model forward passes (not just amortized timesteps) to substantiate the efficiency claim more directly.

## Removed Points
These points are flagged to be removed, treat them with caution:
- **Harsh Critic claimed the theoretical contributions are "largely repackaged standard results"**: While Corollary 3.1 is indeed a data-processing inequality (Markov kernels contract in TV), the paper uses it to motivate the method rather than claiming it as a novel theoretical contribution. The DC-structure formalization (Definition 3.1) targeting molecular distributions specifically is a reasonable descriptive contribution. This criticism overstates the severity.
- **Harsh Critic claimed the method is unreproducible due to unspecified pilot score**: The main text does describe the general mechanism (reverse-simulate pilot subset, evaluate consistency, filter) and the appendix presumably contains the concrete specification. While the opacity is a weakness (see Major), claiming complete unreproducibility is too strong.
- **Harsh Critic questioned whether pilot inference runs from t to 0 or partially**: The paper states it runs "a full reverse inference on a pilot subset" (line 176-177), which clearly implies running to completion (t→0).
- **Strength Finder's "theoretical scaffolding" point** overstates the novelty — Corollary 3.1 is standard and Proposition 3.1's content is not evaluable from the main text.
- **Harsh Critic's claim about missing related work on classifier guidance**: The paper explicitly states "a detailed discussion on the comparison of our work with corrective method is provided in Appendix B." The parser strips appendices; this discussion likely exists in the original submission.

## Novel Insights
The paper's DC-structure formalization — characterizing molecular distributions as mixtures of narrow, well-separated Gaussian peaks — provides a useful lens for understanding why diffusion models underperform on molecular data despite their success on images. The overshoot condition (equation 7) gives a concrete, quantitative condition (β_t · Δ/σ_*² > cσ_*) for when reverse steps will fail, tying the failure mode directly to the narrowness of molecular peaks (small σ_*) rather than to model architecture or training issues. This framework could be fruitfully applied to other domains with highly constrained, multi-modal distributions (e.g., protein conformations, robotic configurations).

## Suggestions
- Specify the concrete pilot score used in the experiments with a one-sentence statement in Section 3.2 (e.g., "We use chemistry-based validity checking on the fully denoised pilot molecules").
- Report the acceptance rate of DIST to allow readers to compute actual computational cost.
- Include a best-of-N baseline at matched compute to isolate the value of mid-trajectory correction from simple post-hoc filtering.
- Report standard deviations for GEOM-Drugs results.

## Calibration Anchors

| Anchor | Avg Score | Round | Comparison |
|--------|-----------|-------|------------|
| TCIG (RFJGFrMvYj) | 1.50 | R1 | Much weaker; fundamentally flawed image generation paper |
| Retrosynthesis (o1efpbvR6v) | 2.33 | R1 | Weaker; different domain, limited results |
| DynamicsDiffusion (kKXIYUi8ff) | 3.00 | R1 | Weaker; MD trajectory generation with diffusion, all 3s |
| PromptDiff (FWsGuAFn3n) | 3.75 | R1 | Weaker; 3D molecular diffusion for drug design |
| Fragment-Augmented Diffusion (r0QqfaCkF8) | 4.33 | R1 | Weaker; conformer generation, limited novelty |
| Molecular Conformer Fields (XSwxy3bojg) | 4.40 | R1 | Weaker; limited novelty, experimental issues |
| MoreRed (rwmWd2rjP1) | 4.75 | R1 | Weaker; methodological concerns, insufficient baselines |
| Subgraph Diffusion (9g8h5HwZMy) | 5.00 | R2 | Weaker; different task (representation learning) |
| Dynamics-Informed Protein Design (jZPqf2G9Sw) | 5.50 | R1 | Slightly weaker; protein domain, narrower scope |
| EQGAT-diff (kzGuiRXZrQ) | 5.75 | R2 | Comparable; empirical design exploration, accepted, our paper has more original conceptual contribution |
| VFDiff (5YLsnsjgeC) | 6.00 | R2 | Comparable; rejected due to similarity to prior work, our paper is more novel |
| Megalodon (9UoBuhVNh6) | 6.33 | R2 | Comparable; stronger empirical results, similar novelty concerns, rejected |
| SyCO / Lift Your Molecules (uNomADvF3s) | 6.50 | R1/R2 | Slightly stronger; more thorough evaluation, accepted |
| GeoBFN (NSVtmmzeRB) | 8.00 | R1 | Stronger; SOTA method with novel Bayesian flow networks |

The paper sits between EQGAT-diff (5.75) and Megalodon (6.33). It has a more original conceptual contribution than EQGAT-diff but less thorough evaluation than SyCO (6.50). The pilot score opacity in the main text is the main factor preventing a higher score.

MY FINAL SCORE: <score>6.0</score>
MY FINAL DECISION: <decision>Accept</decision>